Telephone
61.3.8622.5780
Address
Level 6 720 Bourke Street Docklands, Victoria (VIC) 3008
Description
Medibank Private Ltd. engages in the underwriting and distribution of private health insurance policies through Medibank and ahm brands. It operates through Health Insurance, and Medibank Health segments. The Health Insurance segment offers private health insurance products including hospital cover and ancillary cover, as stand-alone products and packaged products. The Medibank Health segment offers a range of activities including contracting with government and corporate customers to provide health management services, as well as providing a range of telehealth services in Australia. The company was founded in 1976 and is headquartered in Docklands, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.85 - 3.68
Trade Value (12mth)
AU$6,419,124.00
1 week
1.73%
1 month
1.73%
YTD
20.96%
1 year
20.14%
All time high
3.785
EPS 3 yr Growth
62.200%
EBITDA Margin
0.00%
Operating Cashflow
$258m
Free Cash Flow Return
12.60%
ROIC
24.90%
Interest Coverage
0.00
Quick Ratio
0.00
Shares on Issue (Fully Dilluted)
2754m
HALO Sector
Other Finance
Next Company Report Date
21-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.29
Date | Announcements |
---|---|
31 October 23 |
Change of Director's Interest - David Koczkar
×
Change of Director's Interest - David Koczkar |
30 November 16 |
Investor Day - Presentation
×
Investor Day - Presentation |
30 April 19 |
Presentation to Macquarie Australia Conference
×
Presentation to Macquarie Australia Conference |
29 March 23 |
Cybercrime - shareholder class action
×
Cybercrime - shareholder class action |
29 March 22 |
Change of Director's Interest - Gerard Dalbosco
×
Change of Director's Interest - Gerard Dalbosco |
29 June 23 |
Medibank and ahm customers to get $125m back
×
Medibank and ahm customers to get $125m back |
29 June 23 |
Cybercrime - shareholder class action
×
Cybercrime - shareholder class action |
29 April 22 |
Becoming a substantial holder
×
Becoming a substantial holder |
28 November 23 |
Final Director's Interest Notice - Anna Bligh
×
Final Director's Interest Notice - Anna Bligh |
28 November 22 |
Medibank response to APRA
×
Medibank response to APRA |
28 April 23 |
Cybercrime update - Deloitte incident review
×
Cybercrime update - Deloitte incident review |
27 September 22 |
Change of Director's Interest - David Koczkar
×
Change of Director's Interest - David Koczkar |
27 September 22 |
Notification regarding unquoted securities - MPL
×
Notification regarding unquoted securities - MPL |
27 October 15 |
Investor Day - Presentation
×
Investor Day - Presentation |
27 June 23 |
Medibank response to APRA announcement
×
Medibank response to APRA announcement |
27 July 23 |
Executive leadership team update
×
Executive leadership team update |
27 January 23 |
Change in substantial holding
×
Change in substantial holding |
26 October 22 |
Medibank cybercrime, business and FY23 outlook update
×
Medibank cybercrime, business and FY23 outlook update |
26 October 22 |
Reinstatement to Official Quotation
×
Reinstatement to Official Quotation |
25 October 22 |
Medibank cybercrime update
×
Medibank cybercrime update |
25 February 22 |
HY22 Results - Appendix 4D and Financial Report
×
HY22 Results - Appendix 4D and Financial Report |
25 February 22 |
Dividend/Distribution - MPL
×
Dividend/Distribution - MPL |
25 February 22 |
HY22 Results - Media Release
×
HY22 Results - Media Release |
25 February 22 |
HY22 Results - Investor Presentation
×
HY22 Results - Investor Presentation |
25 February 22 |
Medibank appoints non-executive directors
×
Medibank appoints non-executive directors |
25 August 21 |
FY21 Results - Investor Presentation
×
FY21 Results - Investor Presentation |
25 August 17 |
FY17 Results - Investor Presentation
×
FY17 Results - Investor Presentation |
24 March 23 |
Medibank announces John Goodall to retire
×
Medibank announces John Goodall to retire |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.